FDA Inspection
Eisai, Inc.Eisai, Inc. – FDA Inspection, Apr 9, 2024
Record Details
This FDA Inspection record concerns Eisai, Inc., with an inspection on April 9, 2024, issued by the Center for Drug Evaluation and Research.
- Company
- Eisai, Inc.
- Inspection Date
- April 9, 2024
View Company Profile
ID · 80e28e62-e45e-47a5-91af-86da4d269e63
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1237510
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
FDA Citations
3- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eisai, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2026 | Not classified | Baltimore District Office | |
| July 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 17, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 9, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 12, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eisai, Inc.
- FDA Inspection 1335274 - 2026-09-15
- FDA Inspection 977950 - 2016-07-22
- FDA Inspection 860646 - 2013-12-17
- FDA Inspection 722050 - 2011-05-09
- FDA Inspection 669338 - 2010-05-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.